Episode 69:DUPLEX Sparsentan, it’s no Acthar Gel

<p class="" style="white-space:pre-wrap;">The Filtrate:</p><p class="" style="white-space:pre-wrap;"><strong>Joel Topf</strong></p><p class="" style="white-space:pre-wrap;"><strong>Swapnil Hiremath</strong></p><p class="" style="white-space:pre-wrap;"><strong>Priya Yenebere </strong></p><p class="" style="white-space:pre-wrap;"><strong>Nayan Arora</strong></p><p class="" style="white-space:pre-wrap;">With Special Guest:</p><p class="" style="white-space:pre-wrap;"><strong>Brendon Neuen </strong>Super smart guy and clinical trialist</p><p class="" style="white-space:pre-wrap;"><strong>Michelle Rheault </strong>Lead author of DUPLEX and friend of the pod</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"></p><p class="" style="white-space:pre-wrap;"><strong>Show Notes</strong></p><p class="" style="white-space:pre-wrap;">Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis</p><p class="" style="white-space:pre-wrap;"><a href="http://www.nephjc.com/n...